Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

Diabetes Research and Clinical Practice

Volumn 88, Issue 1, 2010, Pages 97-102

  Cruz Gonzalez, Ignacio ^a   Chia, Stanley ^a   Raffel, Owen C ^a   Sanchez Ledesma, Maria ^a   Senatore, Fred ^b   Wackers, Frans J ^c   Nathan, David M ^a   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Mitsubishi Pharma America Inc   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Hyperglycemia; Infarct size; SPECT

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART REINFARCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77949270753     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.01.001     Document Type: Article

References (31)

1. Oswald G.A., Corcoran S., and Yudkin J.S. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1 8389 (1984) 1264-1267
2. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 9206 (2000) 773-778
3. Bellodi G., Manicardi V., Malavasi V., Veneri L., Bernini G., Bossini P., et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am. J. Cardiol. 64 14 (1989) 885-888
4. O'Sullivan J.J., Conroy R.M., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14 8 (1991) 758-760
5. Fava S., Aquilina O., Azzopardi J., Agius Muscat H., and Fenech F.F. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet. Med. 13 1 (1996) 80-83
6. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91 6 (1995) 1659-1668
7. Londahl M., Katzman P., Nilsson A., Ljungdahl L., and Prutz K.G. Cardiovascular prevention before admission reduces mortality following acute myocardial infarction in patients with diabetes. J. Intern. Med. 251 4 (2002) 325-330
8. Stranders I., Diamant M., van Gelder R.E., Spruijt H.J., Twisk J.W., Heine R.J., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch. Intern. Med. 164 9 (2004) 982-988
9. Ishihara M., Kojima S., Sakamoto T., Asada Y., Tei C., Kimura K., et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am. Heart. J. 150 4 (2005) 814-820
10. Ishihara M., Kagawa E., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am. J. Cardiol. 99 12 (2007) 1674-1679
11. Worthley M.I., Holmes A.S., Willoughby S.R., Kucia A.M., Heresztyn T., Stewart S., et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J. Am. Coll. Cardiol. 49 3 (2007) 304-310
12. Shechter M., Merz C.N., Paul-Labrador M.J., and Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J. Am. Coll. Cardiol. 35 2 (2000) 300-307
13. Williams S.B., Goldfine A.B., Timimi F.K., Ting H.H., Roddy M.A., Simonson D.C., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 17 (1998) 1695-1701
14. Kosuge M., Kimura K., Kojima S., Sakamoto T., Matsui K., Ishihara M., et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ. J. 69 4 (2005) 375-379
15. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 41 1 (2003) 1-7
16. Tansey M.J., and Opie L.H. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can. J. Cardiol. 2 6 (1986) 326-331
17. Thomassen A.R., Mortensen P.T., Nielsen T.T., Falstie-Jensen N., Thygesen K., and Henningsen P. Altered plasma concentrations of glutamate, alanine and citrate in the early phase of acute myocardial infarction in man. Eur. Heart J. 7 9 (1986) 773-778
18. Oswald G.A., Smith C.C., Betteridge D.J., and Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br. Med. J. (Clin. Res. Ed.) 293 6552 (1986) 917-922
19. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J. Am. Coll. Cardiol. 44 8 (2004) 1533-1542
20. Jang I.K., Pettigrew V., Picard M.H., Kowey P.R., Demmel V., Zile M.R., et al. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study. J. Thromb. Thrombolysis 20 3 (2005) 147-153
21. Jang I.K., Weissman N.J., Picard M.H., Zile M.R., Pettigrew V., Shen S., et al. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). Am. Heart J. 155 1 (2008) e1-8 113
22. Hansen C.L., Goldstein R.A., Akinboboye O.O., Berman D.S., Botvinick E.H., Churchwell K.B., et al. Myocardial perfusion and function: single photon emission computed tomography. J. Nucl. Cardiol. 14 6 (2007) e39-60
23. Liu Y.H., Sinusas A.J., DeMan P., Zaret B.L., and Wackers F.J. Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CQ method. J. Nucl. Cardiol. 6 2 (1999) 190-204
24. Gibson C.M., Cannon C.P., Daley W.L., Dodge Jr. J.T., Alexander Jr. B., Marble S.J., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 5 (1996) 879-888
25. Sewdarsen M., Vythilingum S., Jialal I., and Becker P.J. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q. J. Med. 71 265 (1989) 461-466
26. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 16 (2002) 2067-2072
27. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36 11 (1993) 1119-1125
28. Shiomi T., Tsutsui H., Ikeuchi M., Matsusaka H., Hayashidani S., Suematsu N., et al. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J. Am. Coll. Cardiol. 42 1 (2003) 165-172
29. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am. Heart J. 146 4 (2003) 674-678
30. Kersten J.R., Montgomery M.W., Ghassemi T., Gross E.R., Toller W.G., Pagel P.S., et al. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am. J. Physiol. Heart Circ. Physiol. 280 4 (2001) H1744-H1750
31. Kosiborod M., Inzucchi S.E., Krumholz H.M., Xiao L., Jones P.G., Fiske S., et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117 8 (2008) 1018-1027